Seattle-based PATH to help produce anti-malarial drug at cost
Malaria remains one of the world’s biggest killers and also a massive economic drag on poor countries, poor families.
One of our best weapons against this scourge is a drug known as artemisinin, which is harvested from the plant sweet wormwood and, as a crop, is about as predictable as corn or hog futures.
A major new initiative to be launched Friday in Italy by Seattle-based PATH in collaboration with the French drug maker Sanofi aims to introduce more predictability – and more of the drug.
Read the rest of the story on Tom Paulson's blog at humanosphere.org.